Virios Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
21 Aug 23 | BuyUS$19,992 | William Pridgen | Individual | 15,335 | US$1.30 | |
17 Aug 23 | BuyUS$31,245 | Gregory Duncan | Individual | 25,000 | US$1.25 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 703,996 | 3.66% |
Institutions | 841,127 | 4.37% |
Individual Insiders | 1,870,329 | 9.71% |
General Public | 15,842,485 | 82.3% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 5.1%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
882,400 | US$398.8k | -33% | no data | |||
761,279 | US$344.1k | 0% | no data | |||
697,292 | US$315.1k | 0% | no data | |||
208,883 | US$94.4k | 0% | no data | |||
206,697 | US$93.4k | 1,380% | no data | |||
174,469 | US$78.9k | 0% | no data | |||
147,681 | US$66.7k | 0% | no data | |||
57,461 | US$26.0k | 0% | no data | |||
52,828 | US$23.9k | 0% | no data | |||
42,000 | US$19.0k | 13.5% | 0.01% | |||
30,000 | US$13.6k | 0% | no data | |||
24,035 | US$10.9k | 0% | no data | |||
22,760 | US$10.3k | 57.6% | no data | |||
20,072 | US$9.1k | 0% | no data | |||
15,000 | US$6.8k | 0% | no data | |||
13,982 | US$6.3k | 21.8% | no data | |||
13,560 | US$6.1k | 0% | no data | |||
12,808 | US$5.8k | 0% | no data | |||
11,000 | US$5.0k | 0% | no data | |||
6,704 | US$3.0k | -23.6% | no data | |||
4,000 | US$1.8k | 0% | no data | |||
3,000 | US$1.4k | 0% | no data | |||
2,600 | US$1.2k | 0% | no data | |||
2,300 | US$1.0k | 0% | no data | |||
1,000 | US$451.7 | 0% | no data |